Recommendations  	Recommendations  	 NNS	B-NP
for  	for  	 IN	O
the  	the  	 DT	O
conduct  	conduct  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
for  	for  	 IN	O
drugs  	drugs  	 NNS	O
to  	to  	 TO	O
treat  	treat  	 VB	O
or  	or  	 CC	O
prevent  	prevent  	 VB	O
sarcopenia  	sarcopenia  	 JJ	B-NP
Sarcopenia  	Sarcopenia  	 NNP	I-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
age-related  	age-related  	 JJ	O
muscle  	muscle  	 NN	B-NP
condition  	condition  	 NN	I-NP
which  	which  	 WDT	O
is  	is  	 VBZ	O
frequently  	frequently  	 RB	O
a  	a  	 DT	O
precursor  	precursor  	 NN	O
of  	of  	 IN	O
frailty 	frailty 	 NN	O
,  	,  	 ,	O
mobility  	mobility  	 JJ	B-NP
disability  	disability  	 NN	I-NP
and  	and  	 CC	O
premature  	premature  	 JJ	O
death 	death 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
has  	has  	 VBZ	O
a  	a  	 DT	O
high  	high  	 JJ	O
prevalence  	prevalence  	 NN	O
in  	in  	 IN	O
older  	older  	 JJR	O
populations  	populations  	 NNS	O
and  	and  	 CC	O
presents  	presents  	 VBZ	O
a  	a  	 DT	O
considerable  	considerable  	 JJ	O
social  	social  	 JJ	O
and  	and  	 CC	O
economic  	economic  	 JJ	B-NP
burden 	burden 	 NN	I-NP
.  	.  	 .	O
Potential  	Potential  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
are  	are  	 VBP	O
under  	under  	 IN	O
development  	development  	 NN	O
but 	but 	 CC	O
,  	,  	 ,	O
as  	as  	 RB	O
yet 	yet 	 RB	O
,  	,  	 ,	O
no  	no  	 DT	O
guidelines  	guidelines  	 NNS	O
support  	support  	 VBP	O
regulatory  	regulatory  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
for  	for  	 IN	O
new  	new  	 JJ	O
drugs  	drugs  	 NNS	O
to  	to  	 TO	O
manage  	manage  	 VB	O
sarcopenia 	sarcopenia 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
position  	position  	 NN	B-NP
paper  	paper  	 NN	I-NP
is  	is  	 VBZ	O
therefore  	therefore  	 RB	O
to  	to  	 TO	O
suggest  	suggest  	 VB	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
potential  	potential  	 JJ	B-NP
endpoints  	endpoints  	 NN	I-NP
and  	and  	 CC	O
target  	target  	 NN	B-NP
population  	population  	 NN	I-NP
definitions  	definitions  	 NNS	I-NP
to  	to  	 TO	O
stimulate  	stimulate  	 VB	O
debate  	debate  	 NN	O
and  	and  	 CC	O
progress  	progress  	 NN	O
within  	within  	 IN	O
the  	the  	 DT	O
medico-scientific  	medico-scientific  	 JJ	O
and  	and  	 CC	O
regulatory  	regulatory  	 JJ	B-NP
communities 	communities 	 NNS	I-NP
.  	.  	 .	O
A  	A  	 DT	O
multidisciplinary  	multidisciplinary  	 JJ	B-NP
expert  	expert  	 NN	I-NP
working  	working  	 VBG	I-NP
group  	group  	 NN	I-NP
was  	was  	 VBD	O
hosted  	hosted  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
European  	European  	 NNP	O
Society  	Society  	 NNP	O
for  	for  	 IN	O
Clinical  	Clinical  	 NNP	O
and  	and  	 CC	O
Economic  	Economic  	 NNP	B-NP
Aspects  	Aspects  	 NNP	I-NP
of  	of  	 IN	I-NP
Osteoporosis  	Osteoporosis  	 NNP	I-NP
and  	and  	 CC	O
Osteoarthritis 	Osteoarthritis 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
reviewed  	reviewed  	 VBD	O
and  	and  	 CC	O
discussed  	discussed  	 VBD	O
the  	the  	 DT	O
recent  	recent  	 JJ	O
literature  	literature  	 NN	O
from  	from  	 IN	O
a  	a  	 DT	O
perspective  	perspective  	 NN	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
experience  	experience  	 NN	I-NP
and  	and  	 CC	O
guideline  	guideline  	 NN	B-NP
development 	development 	 NN	I-NP
.  	.  	 .	O
Relevant  	Relevant  	 JJ	B-NP
parallels  	parallels  	 NNS	I-NP
were  	were  	 VBD	O
drawn  	drawn  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
definition  	definition  	 NN	O
of  	of  	 IN	O
osteoporosis  	osteoporosis  	 NN	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
disease  	disease  	 NN	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
assessment  	assessment  	 NN	I-NP
of  	of  	 IN	I-NP
pharmaceutical  	pharmaceutical  	 JJ	I-NP
treatments  	treatments  	 NNS	I-NP
for  	for  	 IN	O
that  	that  	 DT	O
indication 	indication 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
case-finding  	case-finding  	 JJ	B-NP
decision  	decision  	 NN	I-NP
tree  	tree  	 NN	I-NP
is  	is  	 VBZ	O
briefly  	briefly  	 RB	O
reviewed  	reviewed  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
discussion  	discussion  	 NN	O
of  	of  	 IN	O
recent  	recent  	 JJ	O
prevalence  	prevalence  	 JJ	B-NP
estimations  	estimations  	 NN	I-NP
of  	of  	 IN	O
different  	different  	 JJ	O
relevant  	relevant  	 JJ	O
threshold  	threshold  	 NN	B-NP
values 	values 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
selection  	selection  	 NN	B-NP
criteria  	criteria  	 NNS	I-NP
for  	for  	 IN	O
patients  	patients  	 NNS	O
in  	in  	 IN	O
regulatory  	regulatory  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
discussed  	discussed  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
aims  	aims  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
investigation  	investigation  	 NN	B-NP
( 	( 	 -LRB-	O
sarcopenia  	sarcopenia  	 JJ	B-NP
prevention  	prevention  	 NN	I-NP
or  	or  	 CC	O
treatment 	treatment 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
the  	the  	 DT	O
stage  	stage  	 NN	O
of  	of  	 IN	O
project  	project  	 NN	B-NP
development 	development 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
possible  	possible  	 JJ	O
endpoints  	endpoints  	 NN	B-NP
of  	of  	 IN	O
such  	such  	 JJ	O
studies  	studies  	 NNS	O
are  	are  	 VBP	O
reviewed  	reviewed  	 VBN	O
and  	and  	 CC	O
a  	a  	 DT	O
plea  	plea  	 NN	O
is  	is  	 VBZ	O
made  	made  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
establishment  	establishment  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
core  	core  	 NN	O
outcome  	outcome  	 NN	O
set  	set  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
in  	in  	 IN	O
all  	all  	 DT	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
of  	of  	 IN	I-NP
sarcopenia 	sarcopenia 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
current  	current  	 JJ	O
lack  	lack  	 NN	O
of  	of  	 IN	O
guidelines  	guidelines  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
for  	for  	 IN	I-NP
sarcopenia  	sarcopenia  	 NNS	I-NP
could  	could  	 MD	O
potentially  	potentially  	 RB	O
hinder  	hinder  	 VB	O
the  	the  	 DT	O
delivery  	delivery  	 NN	O
of  	of  	 IN	O
effective  	effective  	 JJ	O
medicines  	medicines  	 NNS	O
to  	to  	 TO	O
patients  	patients  	 NNS	O
at  	at  	 IN	O
risk 	risk 	 NN	O
.  	.  	 .	O
